Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients
Clinical trial NCT00884273 · COMPLETED
Trial details
- NCT number
- NCT00884273
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2011-03-01
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.